Prestige Consumer Healthcare Inc.
PBHNYSECIK 1295947HealthcareFiscal year ends Mar 31
Reports and events: 254 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-08-1416:03 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001295947-26-000049 |
| 2026-08-0606:15 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001295947-26-000042 |
| 2026-08-0606:04 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001295947-26-000040 |
| 2026-07-1516:03 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001104659-26-083872 |
| 2026-07-0916:43 ET | 8-K/A | 9.01 Financial statements and exhibits | 0001295947-26-000032 |
| 2026-07-0608:05 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001295947-26-000029 |
| 2026-06-3006:01 ET | 8-K/A | 9.01 Financial statements and exhibits | 0001295947-26-000025 |
| 2026-06-2906:06 ET | DEF 14A | Proxy statementPeriod 2026-06-29 | 0001295947-26-000021 |
| 2026-06-1606:15 ET | 8-K | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 2.03 New direct financial obligation; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-074259 |
| 2026-05-1416:32 ET | 10-K | Annual reportPeriod 2026-03-31 | 0001295947-26-000016 |
| 2026-05-1316:35 ET | 8-K | 1.01 Entry into a material agreement; 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001295947-26-000013 |
| 2026-03-2006:15 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-032332 |
| 2026-02-0506:09 ET | 10-Q | Quarterly reportPeriod 2025-12-31 | 0001295947-26-000008 |
| 2026-02-0506:04 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001295947-26-000006 |
| 2025-11-0606:11 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001295947-25-000039 |
| 2025-11-0606:03 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001295947-25-000037 |
| 2025-08-0706:15 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001295947-25-000029 |
| 2025-08-0706:07 ET | 8-K | 1.01 Entry into a material agreement; 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001295947-25-000027 |
| 2025-06-2716:04 ET | DEF 14A | Proxy statementPeriod 2025-08-05 | 0001295947-25-000021 |
| 2025-05-0906:06 ET | 10-K | Annual reportPeriod 2025-03-31 | 0001295947-25-000017 |
| 2025-05-0806:04 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001295947-25-000014 |
| 2025-02-0606:08 ET | 10-Q | Quarterly reportPeriod 2024-12-31 | 0001295947-25-000009 |
| 2025-02-0606:03 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001295947-25-000007 |
| 2025-01-0608:00 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001104659-25-001076 |
| 2024-11-0706:11 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001295947-24-000032 |
| 2024-11-0706:03 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001295947-24-000030 |
| 2024-08-0806:10 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001295947-24-000025 |
| 2024-08-0806:03 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001295947-24-000023 |
| 2024-07-0512:00 ET | DEF 14A | Proxy statementPeriod 2024-08-06 | 0001104659-24-078025 |
| 2024-05-1507:01 ET | 10-K | Annual reportPeriod 2024-03-31 | 0001295947-24-000017 |
| 2024-05-1417:04 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001295947-24-000015 |
| 2024-05-0817:08 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001104659-24-058841 |
| 2024-02-0806:10 ET | 10-Q | Quarterly reportPeriod 2023-12-31 | 0001295947-24-000008 |
| 2024-02-0806:05 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001295947-24-000006 |
| 2023-12-1316:01 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001104659-23-125696 |
| 2023-11-0206:11 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0001295947-23-000034 |
| 2023-11-0206:06 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001295947-23-000032 |
| 2023-08-0306:27 ET | 10-Q | Quarterly reportPeriod 2023-06-30 | 0001295947-23-000026 |
| 2023-08-0306:15 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001295947-23-000024 |
| 2023-06-2916:05 ET | DEF 14A | Proxy statementPeriod 2023-08-01 | 0001104659-23-076310 |
| 2023-05-0516:08 ET | 10-K | Annual reportPeriod 2023-03-31 | 0001295947-23-000017 |
| 2023-05-0406:04 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001295947-23-000014 |
| 2023-02-0206:11 ET | 10-Q | Quarterly reportPeriod 2022-12-31 | 0001295947-23-000009 |
| 2023-02-0206:05 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001295947-23-000006 |
| 2022-11-0306:37 ET | 10-Q | Quarterly reportPeriod 2022-09-30 | 0001295947-22-000032 |
| 2022-11-0306:24 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001295947-22-000030 |
| 2022-08-0406:17 ET | 10-Q | Quarterly reportPeriod 2022-06-30 | 0001295947-22-000023 |
| 2022-08-0406:06 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001295947-22-000020 |
| 2022-06-2816:01 ET | DEF 14A | Proxy statementPeriod 2022-08-02 | 0001104659-22-075219 |
| 2022-05-0616:20 ET | 10-K | Annual reportPeriod 2022-03-31 | 0001295947-22-000015 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:10 ET. Listed shows no prices and gives no investment advice.